The Latest Breaking News from Clinical Trial

Uganda initiates Ebola trial after a nurse’s death from the virus.

Uganda launches clinical trial for Ebola vaccine targeting Sudan strain after recent outbreak. Ongoing challenges in East Africa highlight importance of gl...

Summary Delcath Systems (DCTH) shows strong technical buy signals, with a 53.41% gain since 1/25 and a 271.33% gain in the last year. The company focuses on liver cancer treatments, with its leading product HEPZATO KIT and ongoing FOCUS clinical trial for metastatic uveal melanoma. Barchart indicators highlight 100% technical...

With positive results from a clinical trial targeting Type 1 diabetes, Wall Street is feeling hot on this little biotech stock.

Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says.

PROSTATE cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

The vaccine works by harnessing a patient’s own immune system to attack and destroy cancer.

Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables.